Marketfy
Financial Data & APIs
Events
Premarket Prep
Membership is Free
What are you waiting for? Sign up now!
Name:
Username available!
Username taken!
Email:
Email available!
Email taken!
Password:
Leave blank:
OR
Free Account Login
Click here to access your premium account
Username or email:
Password:
OR
Forgot password?
Contribute
Login
Join
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Retail Sales
Offerings
IPOs
Insider Trades
Biotech/FDA
Freight
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
Global Economics
Previews
Reviews
Small-Cap
Cryptocurrency
Penny Stocks
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Catalyst
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Tech
Start-Ups
Fintech
Investing
Best Online Brokers
Personal Finance
Compare Brokers
Ally Invest Review
Binary Options Review
eOption
Etrade Review
Forex.com Review
Interactive Brokers Review
Personal Capital Review
Suretrader Review
TD Ameritrade Review
Tradestation Review
Yewno|Edge Review
Cannabis
Premium
Market Overview
Tickers
Articles
Keywords
Search by keyword...
googlecse
WANT TO CATCH
RSLS
NEWS
BEFORE
IT CHANGES THE STOCK PRICE?
More From
Summary
Ideas
Twitter ($)
All News
Analyst Coverage
Analyst Ratings
News Coverage
News
General
Contracts
Dividend Summaries
Dividend Calendar
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Press Releases
Earnings
Earning Summaries
Earnings Calendar
Guidance Summaries
RESHAPE LIFESCIENCES INC by ReShape Lifesciences Inc.
RSLS
:OTC
Add to Watchlist +
Trade
{{ portfolio.portfolio_name }}
You have no watchlists at this time, click "Manage watchlists" to create your first watchlist.
Manage watchlists
Sector:
Industry:
0.0610
-0.199 (-76.51%)
Data as of Dec 05, 2019
Prev. Close
0.2597
Price Open
Volume
0
Day's Range
-
52 Wk Range
-
50 Day Moving Avg.
PE Ratio
0
Shares Outstanding
Market Cap
Trade RSLS stock with
recommended broker Ally Invest
. Commissions as low as $3.95.
1d
5d
1m
3m
1y
5y
YTD
Analyst Rating
View All Ratings
Date
Research Firm
Action
Current
Target
8/03/18
Ladenburg Thalmann
Downgrades
Buy
Neutral
Headlines
Press Releases
ReShape Lifesciences Announces 1-For-120 Reverse Stock Split Effective Nov. 12
Benzinga Newsdesk
Mon, 11 Nov 2019 12:53:30 -0500
The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering
Shanthi Rexaline
Wed, 14 Aug 2019 06:50:27 -0500
The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout
Shanthi Rexaline
Wed, 07 Aug 2019 06:34:05 -0500
Reshape Lifesciences Q1 EPS $(0.54) Down From $(0.36) YoY, Sales $3.074M Up From $139K YoY
Benzinga Newsdesk
Mon, 20 May 2019 15:23:11 -0500
ReShape Lifesciences FY18 Sales $2.8M Up From $2.3M YoY
Benzinga Newsdesk
Mon, 01 Apr 2019 15:09:42 -0500
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Shanthi Rexaline
Sat, 30 Mar 2019 08:32:40 -0500
48 Biggest Movers From Friday
Lisa Levin
Mon, 31 Dec 2018 05:18:32 -0500
Mid-Afternoon Market Update: Dow Rises 150 Points; Obalon Therapeutics Shares Plunge
Lisa Levin
Fri, 28 Dec 2018 14:21:21 -0500
26 Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Fri, 28 Dec 2018 12:43:17 -0500
Mid-Day Market Update: Crude Oil Up Over 1%; Quantum Shares Spike Higher
Lisa Levin
Fri, 28 Dec 2018 12:18:02 -0500
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
ReShape Lifesciences Announces Third Quarter 2019 Financial Results
ACCESSWIRE
Nov 14, 2019
ReShape Lifesciences Announces 1-for-120 Reverse Stock Split
ACCESSWIRE
Nov 11, 2019
ReShape Lifesciences to Host Third Quarter 2019 Conference Call on November 14, 2019
ACCESSWIRE
Nov 07, 2019
ReShape Lifesciences Announces Strategic Marketing Partnership for LAP-BAND(R)
ACCESSWIRE
Nov 05, 2019
ReShape Lifesciences Appoints Thomas Stankovich as Chief Financial Officer
ACCESSWIRE
Oct 30, 2019
ReShape Lifesciences Announces Attendance and Presentation at Obesity Week 2019
ACCESSWIRE
Oct 17, 2019
ReShape Lifesciences Enters into Early Warrant Exercise Transaction and Receives an Additional $7.65 Million in Proceeds
ACCESSWIRE
Sep 23, 2019
ReShape Lifesciences(TM) to Participate in the H. C. Wainwright Global Investment Conference
ACCESSWIRE
Sep 03, 2019
ReShape Lifesciences(TM) to Highlight Products at IFSO 24th World Congress
ACCESSWIRE
Aug 22, 2019
ReShape Lifesciences Announces Second Quarter 2019 Financial Results
ACCESSWIRE
Aug 14, 2019
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
Partner Headlines
ReShape Lifesciences' (RSLS) CEO Bart Bandy on Q3 2019 Results - Earnings Call Transcript
Seeking Alpha
Nov 14, 2019
ReShape Lifesciences reports Q3 results
Seeking Alpha
Nov 14, 2019
ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q2 2019 Results - Earnings Call Transcript
Seeking Alpha
Aug 14, 2019
ReShape Lifesciences reports Q2 results
Seeking Alpha
Aug 14, 2019
ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q1 2019 Results - Earnings Call Transcript
Seeking Alpha
May 20, 2019
ReShape Lifesciences reports Q1 results
Seeking Alpha
May 20, 2019
ReShape Lifesciences Inc.'s (RSLS) CEO Dan Gladney on Q4 2018 Results - Earnings Call Transcript
Seeking Alpha
Apr 01, 2019
ReShape Lifesciences reports Q4 results
Seeking Alpha
Apr 01, 2019
ReShape Lifesciences announces $2M convertible note financing
Seeking Alpha
Mar 29, 2019
New CEO at ReShape Lifesciences
Seeking Alpha
Mar 26, 2019
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
News Sentiment
Powered by StockSnips
Now:
Bearish
63.16% Positive
Earnings
View Earnings
Q3 2019
EST
Actual
Surprise
EPS:
Expected
2019-11-14
Rev:
Q4 2019
EST
Actual
Surprise
EPS:
Expected
2020-03-30
Rev:
Brokerage Center
Compare All Online Brokerages
Book A Demo
Learn How You Can Succeed In The
Market With Benzinga Pro
Fastest Market News
Real-Time News Alerts
Customizable News Filters
Book A Demo